Abstract

Topical Treatment of Primary Focal Hyperhidrosis, Part 2

Author(s): Zur Eyal

Issue: Mar/Apr 2019 - Volume 23, Number 2

Page(s): 94-104

Download in electronic PDF format for $75

Note: Electronic version includes errata or revisions.

Abstract

This represents part 2 of a 2-part article on the topic of primary focal hyperhidrosis. Part 1, which was published in the International Journal of Pharmaceutical Compounding’s January/February 2019 issue, provided a comprehensive review of the active pharmaceutical ingredients aluminum salts and methenamine in the treatment of primary focal hyperhidrosis. Part 2 provides a comprehensive review of the active pharmaceutical ingredients glycopyrronium salts and oxybutynin chloride in the treatment of primary focal hyperhidrosis.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2001 Pg. 28-29	Topical Therapy for Localized Hyperhidrosis Author(s): Glasnapp Andrew
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Jul/Aug 2019 Pg. 351	Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104. Author(s):
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Jan/Feb 2020 Pg. 7-12	Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets Author(s): Mulder Kyle
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2010 Pg. 322-326	Basics of Compounding: Basics of Compounding with Organic Salts Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 146-153	Basics of Compounding: Basics of Compounding with Inorganic Salts Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 160	Hank's Balanced Salt Solution (Stock Solution) Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 284-290	Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Author(s): Wagner James T
Jan/Feb 2022 Pg. 52	Aluminum Chloride 6.25% in Anhydrous Alcohol Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Mar/Apr 2016 Pg. 164-166	Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Author(s): Nahata Milap C
Nov/Dec 2019 Pg. 447-452	Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Author(s): Mulder Kyle
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Jul/Aug 2019 Pg. 288-293	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Author(s): Zur Eyal
May/Jun 2019 Pg. 200-207	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1 Author(s): Zur Eyal
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal